Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.

Two new 1.5T MRI scanners from GE Healthcare, the Optima MR360 Advance and Brivo MR355 Inspire, have recently received 510(k) clearance. Redesigned with new enclosures symbolizing GE’s Humanizing MRI strategy, both systems are engineered to address the demand for increased performance and reduced total cost of ownership for the facility, while providing a comfortable experience for the patient.

Navidea Biopharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek (technetium Tc 99m tilmanocept) Injection, a novel product indicated for use in lymphatic mapping procedures to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or melanoma. Lymphoseek is a receptor targeted radiopharmaceutical designed to identify these lymph nodes, which have the highest probability of harboring cancer and thereby assist physicians in the staging of such patients.

The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Fourth in the list, they ask that patients and their doctors talk about the real need for a stress echocardiogram if they do not present conditions that would warn them of a risk of heart disease.

For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being used by Loma Linda University Medical Center (LLUMC) to provide physicians improved access to tumors typically regarded as difficult to reach and treat.

Breast Tomosynthesis 3-D Mammography Hologic

Hologic Inc. announced the results of an independent survey by KLAS Research of Hologic 3-D mammography sites in the United States. The in-depth survey, which was not commissioned by Hologic, included fifty respondents whose facilities had used Hologic's 3-D mammography (breast tomosynthesis) technology for at least one year. The researcher reported that "providers are seeing cancers that they would not previously have seen with traditional digital mammography," and concluded that providers who are considering 3-D mammography "would benefit by quickly jumping on the bandwagon."

EOS imaging announced that its next-generation sterEOS 3-D imaging software, sterEOS 1.5, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The sterEOS 1.5 software was highlighted along with the full EOS Imaging System at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 19-23 in Chicago, Ill. The technology is also featured in a paper submitted for the Hip Society Awards, which was presented on Saturday, March 23.

 

Computed Tomography (CT) Colonography Screening Colorectal Cancer

As Americans celebrate National Colorectal Cancer Awareness Month (March), the Colon Cancer Alliance, Colontown — a survivor/patient support group for colorectal disease, including cancer — and the American College of Radiology (ACR) call on Congress to pass the Computed Tomography (CT) Colonography Screening for Colorectal Cancer Act (H.R. 991). Introduced recently by Reps. Ralph Hall (TX-04) and Danny Davis (D-IL), H.R. 991 would require Medicare to cover beneficiaries for CT colonography — otherwise known as virtual colonoscopy.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now